Parent Drug and Active Metabolite (FDA) [Regulatives / Guidelines]

posted by joyjac – Philippines, 2006-05-10 07:44 (7344 d 16:39 ago) – Posting: # 122
Views: 11,657

Dear HS,

Just to clarify in case of (2): 90% CI will be applied to the parent drug and present the metabolite data descriptively - would this mean that ANOVA on the metabolite data is not necessary?

Thanks for sharing your expertise.
Joy

Complete thread:

UA Flag
Activity
 Admin contact
23,654 posts in 4,992 threads, 1,570 registered users;
97 visitors (0 registered, 97 guests [including 15 identified bots]).
Forum time: 00:23 CEST (Europe/Vienna)

“Data! Data! Data!” he cried impatiently.
“I can’t make bricks without clay!”    Arthur Conan Doyle

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5